[1] Branch DW, Gibson M, Silver RM. Clinical practice. Recurrent miscarriage[J]. N Engl J Med, 2010,363(18), 1740-1747 .
[2] McNamee K, Dawood F, Farquharson RG. Thrombophilia and early pregnancy loss[J]. Best Pract Res Clin Obstet Gynaecol, 2012,26(1):91-102 .
[3] Bradley LA, Palomaki GE, Bienstock J, et al. Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?Results from a targeted evidence-based review[J]. Genet Med, 2012,14(1):39-50 .
[4] Brenner B. Hypercoagulability and recurrent miscarriages[J]. Clin Adv Hematol Oncol, 2010, 8(7):467-469 .
[5] Bennett SA, Bagot CN, Arya R.Pregnancy loss and thrombophilia: the elusive link[J]. Br J Haematol, 2012, 157(5):529-542 .
[6] Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review[J]. Br J Haematol, 2006,132(2):171-196 .
[7] Lissalde-Lavigne G, Fabbro-Peray P, Cochery-Nouvellon E, et al. Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control NOHA first' study[J]. J Thromb Haemost,2005, 3(10): 2178-2184 .
[8] Rey E, Kahn SR, David M, et al. Thrombophilic disorders and fetal loss: a meta-analysis[J]. Lancet, 2003, 361(9361): 901-908 .
[9] Finan RR, Tamim H, Ameen G. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population[J]. Am J Hematol,2002,71(4):300-305 .
[10] Dawood F, Farquharson R, Quenby S, et al.Acquired activated protein C resistance may be a risk factor for recurrent fetal loss[J]. Fertil Steril, 2003,80(3), 649-650 .
[11] Lindqvist PG, Svensson P, Dahlback B. Activated protein C resistance in the absence of factor V Leiden and pregnancy[J]. J Thromb Haemost, 2006, 4(2),361-366 .
[12] Rai R, Shlebak A, Cohen H, et al. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage[J]. Hum Reprod, 2001,16(5), 961-965 .
[13] Ren A, Wang J. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis[J]. Fertil Steril, 2006,86(6):1716-1722 .
[14] Greer IA. Antithrombotic Therapy for Recurrent Miscarriage? [J].N Engl J Med,2010, 362(17):1630-1631 .
[15] Tersigni C, Marana R, Santamaria A, et al. In Vitro Evidences of Heparin's Effects on Embryo Implantation and Trophoblast Development[J]. Reprod Sci, 2012,19(5) 454-462 .
[16] Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy[J]. Blood,2005,106(2):401-407 . |